Computational analysis of structure-based interactions and ligand properties can predict efflux effects on antibiotics

European Journal of Medicinal Chemistry
2012.0

Abstract

AcrA-AcrB-TolC efflux pumps extrude drugs of multiple classes from bacterial cells and are a leading cause for antimicrobial resistance. Thus, they are of paramount interest to those engaged in antibiotic discovery. Accurate prediction of antibiotic efflux has been elusive, despite several studies aimed at this purpose. Minimum inhibitory concentration (MIC) ratios of 32 β-lactam antibiotics were collected from literature. 3-Dimensional Quantitative Structure-Activity Relationship on the β-lactam antibiotic structures revealed seemingly predictive models (q(2)=0.53), but the lack of a general superposition rule does not allow its use on antibiotics that lack the β-lactam moiety. Since MIC ratios must depend on interactions of antibiotics with lipid membranes and transport proteins during influx, capture and extrusion of antibiotics from the bacterial cell, descriptors representing these factors were calculated and used in building mathematical models that quantitatively classify antibiotics as having high/low efflux (>93% accuracy). Our models provide preliminary evidence that it is possible to predict the effects of antibiotic efflux if the passage of antibiotics into, and out of, bacterial cells is taken into account--something descriptor and field-based QSAR models cannot do. While the paucity of data in the public domain remains the limiting factor in such studies, these models show significant improvements in predictions over simple LogP-based regression models and should pave the path toward further work in this field. This method should also be extensible to other pharmacologically and biologically relevant transport proteins.

Knowledge Graph

Similar Paper

Computational analysis of structure-based interactions and ligand properties can predict efflux effects on antibiotics
European Journal of Medicinal Chemistry 2012.0
Quantitative structure–activity relationship (QSAR) of aryl alkenyl amides/imines for bacterial efflux pump inhibitors
European Journal of Medicinal Chemistry 2009.0
Kinetic Parameters of Efflux of Penicillins by the Multidrug Efflux Transporter AcrAB-TolC of Escherichia coli
Antimicrobial Agents and Chemotherapy 2010.0
Design and structural optimization of novel 2H-benzo[h]chromene derivatives that target AcrB and reverse bacterial multidrug resistance
European Journal of Medicinal Chemistry 2021.0
Identification and Structure–Activity Relationships of Novel Compounds that Potentiate the Activities of Antibiotics in Escherichia coli
Journal of Medicinal Chemistry 2017.0
Quantitative structure activity relationship (QSAR) of piperine analogsfor bacterial NorA efflux pump inhibitors
European Journal of Medicinal Chemistry 2009.0
Evaluation of a series of 2-napthamide derivatives as inhibitors of the drug efflux pump AcrB for the reversal of antimicrobial resistance
Bioorganic & Medicinal Chemistry Letters 2017.0
Substrate Competition Studies Using Whole-Cell Accumulation Assays with the Major Tripartite Multidrug Efflux Pumps of Escherichia coli
Antimicrobial Agents and Chemotherapy 2007.0
Single Nucleotide Polymorphism Analysis of the Major Tripartite Multidrug Efflux Pump of Escherichia coli : Functional Conservation in Disparate Animal Reservoirs despite Exposure to Antimicrobial Chemotherapy
Antimicrobial Agents and Chemotherapy 2010.0
De Novo Prediction of P-Glycoprotein-Mediated Efflux Liability for Druglike Compounds
ACS Medicinal Chemistry Letters 2013.0